Quattro Financial Advisors LLC
- SEC CIK
- 0001705929
- Latest filing
- Jul 16, 2026
DNA holding history
Ginkgo Bioworks Holdings, Inc. in every 13F filed by Quattro Financial Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNA overviewAll 13F holders of DNAFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −5,000−100.0% | Sold outConverted for a 1-for-40 split | Holders |
| Q2 2024 | 200,000 | $66.9K | <0.1% | +25,000+14.3% | Added | Holders |
| Q1 2024 | 175,000 | $203.0K | 0.1% | +174,998+8,749,900.0% | Added | Holders |
| Q4 2023 | 2 | $295.8K | 0.1% | −174,998−100.0% | Reduced | Holders |
| Q3 2023 | 175,000 | $316.8K | 0.1% | +75,000+75.0% | Added | Holders |
| Q2 2023 | 100,000 | $186.0K | 0.1% | +100,000 | New | Holders |